April 26, 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.
March 27, 2018
The methods of financing biotech R&D are evolving as large pharma companies and governments look to small biotech start-ups to provide the next generation of medicines.
February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.
November 24, 2017
As India’s domestic pharmaceutical market becomes increasingly crowded and the industry as a whole continues along the path of globalization, ...
October 19, 2017
The largest supplier of generic drugs globally, India continues to fortify its reputation as a hub for the production of affordable quality medicines.
September 06, 2017
The largest supplier of generic drugs globally, India continues to fortify its reputation as a hub for the production of affordable quality medicines.
June 19, 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.
June 19, 2017
Maintaining Safeguards Whilst Lowering Barriers to Market Entry.
May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.
May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.